Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease

Table 2 Comparison of patient characteristics before surgery in the two groups

Index	ESBD group (n = 43)	ESLD group (n = 86)	P value
Age (yr)1	40.2 ± 15.5 (0.5-65)	43.2 ± 15.3 (5-65)	0.105
Gender (M:F)2	28:15 (65%:35%)	56:30 (65%:35%)	1.000
WBC (× 109/L)1	6.7 ± 4.3 (1.1-23.4)	6.1 ± 4.5 (1.3-24.5)	0.178
Hb (g/L)1	103.3 ± 22.6 (47.2-149)	102.3 ± 20.1 (55-154)	0.798
Plt (× 109/L)1	126.0 ± 59.6 (37-247)	91.0 ± 74. 6 (11-379)	0.000
TBIL (mg/dL)1	17.0 ± 13.8 (1.29-47.57)	9.4 ± 5.4 (0.96-22.16)	0.030
INR1	1.3 ± 0.4 (0.86-2.35)	1.829 ± 0.648 (1.12-5.57)	0.000
Cr (mg/dL)1	0.9 ± 0.8 (0.15-3.92)	1.1 ± 0.8 (0.35-5.06)	0.042
Alb (g/L)1	35.1 ± 4.7 (26-50.5)	33.4 ± 3.4 (28-44.3)	0.016
ALT (U/L)1	122.6 ± 96.3 (28-399)	112.9 ± 167.2 (26.5-1400)	0.156
γ-GT (U/L)1	515.7 ± 578.2 (17-2374)	119.9 ± 119.6 (11.7-588)	0.000
MELD/PELD score1	19.2 ± 6.6 (8-39)	22.0 ± 6.5 (11-38)	0.023
Previous surgery1	1.8 ± 1.3 (0-5)	0.1 ± 0.2 (0-1)	0.000

¹Data are presented as the mean ± SD; ranges are provided in the parentheses;

²Data are presented as the n (%). MELD risk score = [0.957 × log (creatinine; mg/L) + 0.378 × log (bilirubin; mg/dL) + 1.120 × log (INR) + 0.643] × 10. Used for patients aged 12 years and older. Laboratory values less than 1.0 were set to 1.0 to calculate the MELD score. PELD risk score = [0.48 × log (bilirubin; mg/dL) + 1.857 × log (INR) - 0.687 × log (albumin) + infants less than 1 year 0.436 + growth failure 0.667] × 10. Used for patients aged 11 years and younger. Laboratory values less than 1.0 were set to 1.0 to calculate the PELD score. WBC: White blood cell; Hb: Hemoglobin; PLT: Platelets; TBIL: Total bilirubin; INR: International normalised ratio; Cr: Serum creatinine; Alb: Albumin; ALT: Alanine transarninase; r-GT: Glutamyl transpeptidase; MELD: Model for end-stage liver disease; PELD: Paediatric end-stage liver disease.